CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Works matching IS 00316970 AND DT 2006 AND VI 62 AND IP 1
Results: 17
1
2
Safety implications regarding use of phytomedicines.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 37, doi. 10.1007/s00228-005-0050-6
- By:
- Publication type:
- Article
3
Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 43, doi. 10.1007/s00228-005-0059-x
- By:
- Publication type:
- Article
4
Response to Naunton and Duyvendak re “Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?”.
- Published in:
- 2006
- By:
- Publication type:
- Letter
5
Impact of the CYP2D6 metaboliser status on the pupillary response of tramadol—a commentary.
- Published in:
- 2006
- By:
- Publication type:
- Letter
6
Improving the performance of Drug and Therapeutics Committees in hospitals – a quasi-experimental study in Laos.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 57, doi. 10.1007/s00228-005-0069-8
- By:
- Publication type:
- Article
7
Herbal medicines – they are popular, but are they also safe?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
8
Underuse of antiplatelets and inappropriate use.
- Published in:
- 2006
- By:
- Publication type:
- Letter
9
Treatment of chorea with levetiracetam.
- Published in:
- 2006
- By:
- Publication type:
- Letter
10
The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 51, doi. 10.1007/s00228-005-0065-z
- By:
- Publication type:
- Article
11
Evaluation of the effect of multiple-dose administration of R411, a dual α4β1–α4β7 integrin antagonist on the major CYP isoform activities in healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 83, doi. 10.1007/s00228-005-0067-x
- By:
- Publication type:
- Article
12
Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 15, doi. 10.1007/s00228-005-0066-y
- By:
- Publication type:
- Article
13
The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 29, doi. 10.1007/s00228-005-0061-3
- By:
- Publication type:
- Article
14
Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 3, doi. 10.1007/s00228-005-0064-0
- By:
- Publication type:
- Article
15
Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 65, doi. 10.1007/s00228-005-0027-5
- By:
- Publication type:
- Article
16
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 23, doi. 10.1007/s00228-005-0057-z
- By:
- Publication type:
- Article
17
Effect of pravastatin on plasma sterols and oxysterols in men.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 1, p. 9, doi. 10.1007/s00228-005-0068-9
- By:
- Publication type:
- Article